Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri

Annals of Oncology

Volumn 11, Issue 4, 2000, Pages 455-459

  Pignata, S ^a   Frezza, P ^a   Tramontana, S ^a   Perrone, F ^a   Tambaro, R ^a   Casella, G ^a   Ferrari, E ^a   Iodice, F ^a   De Vivo, R ^a   Ricchi, P ^a   Tramontana, F ^a   Silvestro, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cervical cancer; Chemotherapy; Phase I; Radiotherapy

Indexed keywords

CISPLATIN; PACLITAXEL;

ADULT; AGED; ALOPECIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTITIS; DIARRHEA; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MYALGIA; NEUROTOXICITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; PACLITAXEL; TAXOIDS; UTERINE CERVICAL NEOPLASMS;

EID: 0034126461     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008379922120     Document Type: Article

References (29)

1. Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Engl J Med 1996; 334: 1030-8.
2. Jones WB, Shingleton HM, Russell A et al. Patterns of care for invasive cervical cancer. Results of a national survey of 1984 and 1990. Cancer 1995; 76 (Suppl 10): 1934-47.
3. Braly PS, Lichter AS, Ash DK et al. Proc NIH Consensus Develop Conf Cervical Cancer 1996; 1-29.
4. Vokes EE, Weichselbaum RR. Concomitant chemotherapy: Rational and clinical experience in patients with solid tumors. J Clin Oncol 1990; 8: 911-34.
5. Rose PG. Locally advanced cervical carcinoma: The role of chemoradiation. Semin Oncol 1994; 21: 47-53.
6. Hreschyshyn MM, Aron BS, Boronow RC et al. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys 1979; 5: 317-22.
7. Piver MS, Barlow JJ, Vongtama V. Hydroxyurea and radiation therapy in advanced cervical cancer. Am J Obstet Gynecol 1977; 120: 969-72.
8. Stehman FB, Bundy BN, Thomas G et al. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: Long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol 1993; 11: 1523-8.
9. Piver MS, Vongtama V, Emrich LJ. Hydroxyurea plus pelvic radiation versus pelvic radiation in surgically staged stage IIIB cervical cancer. J Surg Oncol 1987; 35: 129-34.
10. Malfetano J, Keys H, Kredentser D et al. Weekly cisplatin and radical radiation therapy for advanced, recurrent and poor prognosis cervical carcinoma. Cancer 1993; 72: 11-6.
11. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137-43.
12. Keys HM, Bundy BN, Stehman FB et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage Ib cervical carcinoma. N Engl J Med 1999; 340: 1154-61.
13. Peters WA III, Liu PY, Barrett L et al. Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy. Proc Soc Gynecol Oncol 1999; 28.
14. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144-53.
15. Whitney CW, Sause W, Bundy BN et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17: 1339-48.
16. Pignata S, De Vivo R, Ricchi P et al. Chemotherapy in squamous cell carcinoma of the cervix uteri: Present role and perspectives. Cancer Treat Rev 1998; 24: 27-34.
17. Kudelka AP, Winn R, Edwards CL et al. Activity of paclitaxel in advanced or recurrent squamous-cell cancer of the cervix. Clin Cancer Res 1996; 2: 1285-8.
18. Rose PG, Blessing JA, Gershenson DM, McGehee R. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous carcinoma of the cervix: A Gynaecologic Oncology Group study. J Clin Oncol 1999; 17: 2676-80.
19. Papadimitriou CA, Sarris K, Moulopoulos LA et al. Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. J Clin Oncol 1999; 17: 761-6.
20. Tishler RB, Geard R, Hall EJ et al. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 1992; 52: 3495-7.
21. Liebmann J, Cook JA, Fisjer J et al. In vitro studies of Taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst 1994; 86: 441-6.
22. Conley B, Jacobs M, Suntharalingam M et al. A pilot trial of paclitaxel, carboplatin and concurrent radiotherapy for unresectable squamous cell carcinoma of the head and neck. Semin Oncol 1997; 24 (Suppl 2): 78-80.
23. Belani CP, Aisner J, Bahri S et al. Chemoradiotherapy in non-small-cell lung cancer: Paclitaxel-carboplatin-radiotherapy in regionally advanced disease. Semin Oncol 1996; 23 (Suppl 16): 113-6.
24. Frasci G, Comella P, Scoppa G et al. Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: A phase I study. J Clin Oncol 1997; 15: 1409-17.
25. Miller AB, Hoogstraten B, Staquet M et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
26. Omura GA. Chemotherapy for cervix cancer. Semin Oncol 1994; 21: 54-62.
27. Begg AC, Bohlken S, Bartelink H. The effect of cisplatin on the repair of radiation damage in RIF1 mouse tumors in vivo. Radiother Oncol 1989; 15: 79-91.
28. Schaake-Koning C, van den Bogaert W, Dalesio O et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992; 326: 524-30.
29. Chen MD, Paley PJ, Polish RA et al. Phase 1 trial of Taxol as a radiation sensitizer with cisplatin in advanced cervical cancer. Gynecol Oncol 1997; 67: 131-6.